Healthcare -
Biotechnology - NASDAQ - US
$ 4.16
-11.7 %
$ 86.5 M
Market Cap
-0.7
P/E
ADVM - CASH FROM OPERATIONS
Cash from Operations ADVM - Adverum Biotechnologies, Inc.
-90.9 M
LAST VALUE
8.18%
2 YEAR CAGR
-10.99%
5 YEAR CAGR
-45.25%
10 YEAR CAGR